• Dantrolene Sodium Salt: RyR Workflow Guide

  2026-09-01

  Dantrolene sodium salt provides a targeted way to interrogate ryanodine receptor-driven calcium release in cardiac, pancreatitis, neurodegeneration, and stress models. This guide distinguishes validated calcium-signaling applications from an exploratory strategy that pairs calcium perturbation with CRISPR DNA-repair profiling.

• H4K12 Lactylation Drives TNBC via SLFN5

  2026-08-31

  The reference study identifies a lactate–H4K12 lactylation–SLFN5 axis that connects altered glycolysis with apoptosis suppression and malignancy progression in triple-negative breast cancer. Its combination of tissue analysis, metabolic perturbation, chromatin profiling, promoter assays, and rescue experiments provides a mechanistic framework for cancer metabolism research and related tumor bioenergetics studies.

• Alda 1: A Causal Framework for ALDH2 Research

  2026-08-30

  Alda 1 is an ALDH2 activator that connects aldehyde detoxification with cardiomyocyte biology, ischemic injury, and radiation response. This article presents a causal, assay-focused framework for interpreting ALDH2 activation across distinct experimental models.

• Everolimus (RAD001) Cancer Assay Workflows

  2026-08-29

  Build more informative mTOR experiments with Everolimus (RAD001), combining pathway pharmacodynamics, proliferation measurements, and orthogonal cell-death assays. This workflow separates growth arrest from killing so researchers can interpret dose responses more reliably across cancer models.

• Midecamycin Workflows for Macrolide Research

  2026-08-29

  Midecamycin is an acetoxy-substituted macrolide antibiotic that supports mechanism-driven Gram-positive susceptibility testing, resistance modeling, and glycosylation studies. This practical guide connects concentration design, solvent handling, strain engineering insights, and troubleshooting for more reproducible antibacterial experiments.

• PR-619: Practical DUB Inhibitor Assay Guide

  2026-08-28

  PR-619 (SKU A8212) is a cell-permeable, reversible deubiquitylating enzymes inhibitor for probing broad cysteine-dependent DUB activity in cell-based assays. This guide covers formulation, dosing, controls, and interpretation while distinguishing DUB perturbation from proteasome inhibition and identifying situations where cytotoxicity or assay-specific effects limit conclusions.

• Phosphatase Inhibitor Cocktail: Workflow Guide

  2026-08-28

  Learn how a dual-component phosphatase inhibitor system preserves phosphorylation during lysis, immunoblotting, immunoprecipitation, kinase assays, and phosphoproteomics. The guide connects practical sample handling with recent evidence on ROS–ZAKα signaling in endometrial cancer and provides troubleshooting strategies for reproducible phospho-readouts.

• GCRV104 Entry: Clathrin-Mediated Endocytosis

  2026-08-27

  Wang et al. used pharmacological inhibition, transmission electron microscopy, and real-time qPCR to define how genotype III grass carp reovirus enters CIK cells. Their results identify a dynamin-dependent, acidification-sensitive clathrin pathway while showing that latrunculin B-sensitive actin polymerization is not required under the tested conditions.

• Alpha-Ketoglutarate Assays in Tumor Metabolism

  2026-08-27

  Alpha-ketoglutarate is more than a TCA-cycle intermediate: it is a controllable variable linking carbon flux, nitrogen handling, and macrophage function. This assay-focused guide translates recent cholangiocarcinoma findings into practical experimental decisions without confusing metabolite supplementation with endogenous metabolic accumulation.

• ALDH2 Activation Delays Pressure-Overload Heart Failure

  2026-08-26

  A 2025 Experimental Cell Research study shows that activating ALDH2 can extend the postnatal proliferative window of mouse cardiomyocytes and enhance cardiomyocyte proliferation in adult mice exposed to pressure overload. The findings position ALDH2 as a potential link between aldehyde detoxification, cardiac stress responses, and myocardial regeneration, while leaving important questions about mechanism, durability, and human translation unresolved.

• SCH772984: Designing Rigorous ERK1/2 Assays

  2026-08-26

  SCH772984 is a selective ERK1/2 inhibitor for dissecting MAPK signaling in mutant cancer models. This guide connects biochemical potency with phospho-signaling, ferroptosis, radioresistance, and in vivo assay design without overstating evidence.

• Arachidonic Acid and Rapid Vaccine Immunity

  2026-08-25

  A 2025 study reported that dietary arachidonic acid enhanced rabies vaccine-induced neutralizing antibodies and improved protection in mice, while oral supplementation accelerated protective antibody development in human volunteers. The work links lymph-node arachidonic acid metabolism to a prostaglandin I2–cAMP–PKA pathway involving CD86 and activation-induced cytidine deaminase, suggesting a dietary route for strengthening germinal-center responses.

• One-step TUNEL Cy5 Apoptosis Detection Kit Workflow

  2026-08-25

  Apply Cy5-based DNA fragmentation detection across osteonecrosis models, tissue sections, and cultured cells with a workflow designed for spatial imaging or flow cytometry. This guide connects the One-step TUNEL Cy5 Apoptosis Detection Kit to the PTX3–TLR4/NF-κB/FGF21 findings in a recent osteonecrosis study while emphasizing controls, optimization, and interpretation limits.

• Cinoxacin: Mechanism, Spectrum, and Clinical Evidence

  2026-08-24

  The reference paper integrates Cinoxacin’s DNA synthesis inhibition, antibacterial spectrum, pharmacokinetics, adverse reactions, and clinical performance in urinary tract infections. Its central contribution is to define Cinoxacin as a urinary-focused quinolone antibiotic with activity against important Enterobacteriaceae, while clarifying resistance overlap, renal elimination, and limitations against Pseudomonas and Gram-positive organisms.

• N-Formimidoyl Thienamycin vs β-Lactams: 1982 Study

  2026-08-23

  Cullmann and colleagues compared N-formimidoyl thienamycin (MK0787) with several contemporary β-lactam antibiotics across 470 clinical isolates, emphasizing resistant Enterobacteriaceae, nonfermenting gram-negative organisms, and selected gram-positive bacteria. The study showed that MK0787 combined broad antibacterial activity with strong bactericidal behavior against gram-negative isolates and activity that was largely independent of β-lactamase production.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page